Lupus Nephritis Clinical Trials in St Louis, Missouri

4 studies are recruiting for lupus nephritis in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. VIBRANT: VIB4920 for Active Lupus Nephritis

    This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Washington University School of Medicine in St. Louis: Division of Nephrology, St Louis, Missouri
    Locations
    17 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT05201469 on ClinicalTrials.gov

  2. The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

    The study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBSA; 600mg/m2 body surface area per dose about every 12 hours) and (2) pharmacokinetically-guided precision-dosing of MMF (MMFPK; MMF dosed twice daily …

    Stage
    Phase 2
    Ages
    8 to 20
    Site
    Washington University in St. Louis School of Medicine, St Louis, Missouri
    Locations
    19 in total
    Run by
    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT05538208 on ClinicalTrials.gov

  3. A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

    This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune diseases, including active systemic lupus erythematosus (SLE), systemic sclerosis (SSc), or idiopathic inflammatory myopa…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    16 in total
    Run by
    CRISPR Therapeutics

    See if you can join NCT06925542 on ClinicalTrials.gov

  4. Lupus Landmark Study: A Prospective Registry and Biorepository

    The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

    Stage
    Not phased
    Ages
    18 to 110
    Site
    Washington University, St Louis, Missouri
    Locations
    25 in total
    Run by
    Lupus Research Alliance

    See if you can join NCT05934149 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.